12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·08/24/2026 17:06:05
Listen to the news
Gainers
- Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular session. The market value of their outstanding shares is at $5.8 million.
- Picard Medical (AMEX:PMI) shares increased by 39.25% to $4.47. The company's market cap stands at $6.5 million. As per the news, the Q2 earnings report came out 3 days ago.
- Aprea Therapeutics (NASDAQ:APRE) stock increased by 23.52% to $0.79. The company's market cap stands at $8.0 million.
- Alvotech (NASDAQ:ALVO) stock increased by 18.22% to $5.24. The company's market cap stands at $1.4 billion. As per the press release, Q2 earnings came out 3 days ago.
- Biomea Fusion (NASDAQ:BMEA) stock moved upwards by 16.78% to $1.6. The market value of their outstanding shares is at $99.3 million.
- Nutriband (NASDAQ:NTRB) shares increased by 15.08% to $5.37. The market value of their outstanding shares is at $56.7 million.
Losers
- Regenxbio (NASDAQ:RGNX) stock fell 25.3% to $8.01 during Monday's regular session. The company's market cap stands at $707.6 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 22.92% to $0.09.
- Addex Therapeutics (NASDAQ:ADXN) stock fell 22.07% to $3.85. The company's market cap stands at $6.0 million.
- Kairos Pharma (AMEX:KAPA) shares decreased by 20.69% to $0.23. The market value of their outstanding shares is at $6.8 million.
- Adial Pharmaceuticals (NASDAQ:ADIL) shares decreased by 18.13% to $5.09. The market value of their outstanding shares is at $16.3 million.
- Profusa (NASDAQ:PFSA) shares declined by 17.95% to $4.48. The market value of their outstanding shares is at $2.8 million. As per the press release, Q2 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.